Algo version: 0.98b
INKT is listed at the NASDAQ Exchange
INKT [INKT]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is INKT stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for MiNK Therapeutics, Inc. 10 years ago, but if you had invested on Friday 15th of October 2021 when the price was $12.00, you would have made a loss of $-11.31 per share or -94.25%

No, the average daily trading liquidity for MiNK Therapeutics, Inc. is $46 708 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

MiNK Therapeutics, Inc. has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company has a very low net profit margin of 0.15%, which is challenging.

We have calculated the inflation risk for MiNK Therapeutics, Inc. to be medium [0.65 out of 1]